p53 expression and TGF-α-induced replication of hepatocytes isolated from rats exposed to the carcinogen diethylnitrosamine

Cell Biology and Toxicology

Volumn 15, Issue 1, 1999, Pages 31-39

  Lennartsson, P ^a   Stenius, Ulla ^a   Hogberg J ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

Author keywords

Diethylnitrosamine; EGF receptor; Enzyme altered foci; Hepatocytes; P53; TGF

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; PROTEIN P53; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL DAMAGE; CELL DIVISION; CELL ISOLATION; DNA REPLICATION; FEMALE; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LABELING INDEX; LIVER CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SEQUENCE ANALYSIS;

ANIMALS; CARCINOGENS; CELL DIVISION; CELLS, CULTURED; DIETHYLNITROSAMINE; DNA REPLICATION; FEMALE; GLUTATHIONE TRANSFERASE; LIVER; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 0032913852     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007598522366     Document Type: Article

References (21)

1. Bellamy COC, Clark AR, Wyllie AH, Harrison DJ. p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J. 1997;11:591-9.
2. Burr AW, Toole K, Matthew J, Hines JE, Chapman C, Burt AD. Transforming growth factor-α expression is altered during experimental hepatocarcinogenesis. J Hepatol. 1996;179:276-82.
3. DeCicco LA, Kong J, Ringer DP. Carcinogen-induced alteration in liver epidermal growth factor receptor distribution during the promotion stage of hepatocarcinogenesis in rats. Cancer Lett. 1997;111:149-56.
4. Ha, v-fos, or human transforming growth factor α. Cancer Res. 1996;56: 4413-23.
5. Kaufmann WK, Zhang Y, Kaufmann DG. Association between expression of TGFα and progression of hepatocellular foci to neoplasms. Carcinogenesis. 1992;13:1481-3.
6. Lee GH, Merlino G, Fausto N. Development of liver tumors in transforming growth factor-α transgenic mice. Cancer Res. 1992;52:5162-70.
7. Lennartsson P, Högberg J, Stenius U. Wild-type p53 expression in liver tissue and in enzyme-altered foci; an in vivo investigation on diethylnitrosamine-treated rats. Carcinogenesis. 1998;19:1231-7.
8. Manjeshwar S, Rao PM, Rajalakshmi S, Sarma DSR. Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal rat liver and from hepatic nodules. Carcinogenesis. 1992;13:2287-91.
9. Ogasawara H, Hiramoto J, Shirahama K et al. Hepatocyte growth factor stimulates the growth of hepatocytes in altered foci and hyperplastic nodules induced by chemical hepatocarcinogenesis in rats. Int Hepat Commun. 1995;3: 296-304.
10. Pitot HC. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol. 1990;30:465-500.
11. Reddy KB, Chen YO. Molecular mechanism of EGF induced apoptosis in cancer cells. Abstract, AACR annual meeting, New Orleans, 1998:142.
12. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Mullauer L, Ruttkay-Nedecky B. Apoptosis and multistage carcinogenesis in rat liver. Mutat Res Fundam Mol Mech Mutat. 1995;333:81-7.
13. Sheikh MS, Carrier F, Johnson AC, Ogdon SE, Fornace AJ Jr. Identification of an additional p53-responsive site in the human epidermal growth factor receptor gene promoter. Oncogene. 1997;15:1095-101.
14. Shi YE, Yager JD. Regulation of rat hepatocyte epidermal growth factor receptor by the liver tumor promoter ethinyl estradiol. Carcinogenesis. 1990;11:1103-9.
15. Stenius U. Different inhibition of DNA synthesis by transforming growth factor β and phenobarbital on GST-P-positive and GST-P-negative hepatocytes. Carcinogenesis. 1993;14: 159-61.
16. Stenius U, Högberg J. GST-P positive hepatocytes isolated from rats bearing enzyme-altered foci show no signs of p53 induction and replicate even when their DNA contains strand breaks. Carcinogenesis. 1995;16:1683-6.
17. Stenius U, Warholm M, Martens U, Högberg J. Isolation of glutathione S-transferase P-positive hepatocytes from carcinogen treated rats by use of ethacrynic acid as selecting agent. Carcinogenesis. 1994;15:1561-6.
18. Tanno S, Ogawa K. Abundant TGFa precursor and EGF receptor expression as a possible mechanism for the preferential growth of carcinogen-induced preneoplastic and neoplastic hepatocytes in rats. Carcinogenesis. 1994;15: 1689-94.
19. Tsuji K, Ogawa K. Recovery from ultraviolet-induced growth arrest of primary rat hepatocytes by p53 antisense oligonucleotide treatment. Mol Carcinogen. 1994;9:167-74.
20. Van Gijssel HE, Maassen CBM, Mulder GJ, Meerman JHN. p53 protein expression by hepatocarcinogens in the rat liver and its potential role in mitoinhibition of normal hepatocytes as a mechanism of hepatic tumour promotion. Carcinogenesis. 1997;18:1027-33.
21. Van Winkel LS, Isaac JM, Plopper CG. Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am J Pathol. 1997;151:443-59.